Laninamivir Octanoate

• CAT Number: R050807
• CAS Number: 203120-46-1
• Molecular Formula: C21H36N4O8
• Molecular Weight: 472.53
• Purity: ≥95%
• Synonyms: 5-(Acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-7-O-methyl-D-glycero-D-galacto-non-2-enonic Acid 9-Octanoate; (2R,3R,4S)-3-Acetamido-4-?guanidino-2-[(1R,2R)-2-hydroxy-1-methoxy-3-(octanoyloxy)propyl]-3,4-dihydro-2H-pyran-6-carb
• Target: Influenza Virus
• Storage: -20°C
• IUPAC Name: (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-2-hydroxy-1-methoxy-3-octanoyloxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid
• InChI: InChI=1S/C21H36N4O8/c1-4-5-6-7-8-9-16(28)32-11-14(27)18(31-3)19-17(24-12(2)26)13(25-21(22)23)10-15(33-19)20(29)30/h10,13-14,17-19,27H,4-9,11H2,1-3H3,(H,24,26)(H,29,30)(H4,22,23,25)/t13-,14+,17+,18+,19+/m0/s1
• InChIKey: UKTIJASCFRNWCB-RMIBSVFLSA-N
• SMILES: CCCCCCCC(=O)OC[C@H]([C@H]([C@H]1[C@@H]([C@H](C=C(O1)C(=O)O)N=C(N)N)NC(=O)C)OC)O

Laninamivir Octanoate（Cat No.:R050807）is a long-acting neuraminidase inhibitor used as an antiviral agent against influenza A and B viruses. Administered via inhalation, it is converted in the respiratory tract to laninamivir, its active form, which blocks viral neuraminidase enzymes, preventing viral replication and release from infected cells. Its prolonged action allows for a single-dose treatment, offering convenience and adherence benefits, especially during flu outbreaks. Laninamivir Octanoate has shown efficacy in reducing the duration and severity of flu symptoms, making it a valuable tool in influenza management and prevention.